Home » Newsletters » BioWorld

BioWorld

April 26, 1994

View Archived Issues

GENZYME'S EXPORTS TO GET ROYAL ENCOMIUM

CORRECTION and AMPLIFICATION

QUEEN HONORS CRUACHEM FOR EXPORT PROWESS

IDEC ANTIBODY IN PHASE II FOR LYMPHOMA

ZYNAXIS PRESENTS DATA FOR ARTHRITIS

COHESIVE BIOTECH PLANS FIRST SHIPMENT

DRUG ROYALTY, CAT INTEND TO COLLABORATE

INCYTE, LAYTON TEAM TO SPEED GENE SEQUENCING

BIOTECH EXECS COURT KENNEDY

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.